Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1
暂无分享,去创建一个
M. Jinnin | H. Ihn | Y. Mimura | Y. Asano | Masatoshi Jinnin | Hironobu Ihn | Yoshihide Asano | K. Yamane | K. Tamaki | Kunihiko Tamaki | Yoshihiro Mimura | Kenichi Yamane
[1] A. Eisen,et al. Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. , 1986, The Journal of biological chemistry.
[2] J. Lautenberger,et al. Mammalian ets-1 and ets-2 genes encode highly conserved proteins. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[3] Ken Yagi,et al. c-myc Is a Downstream Target of the Smad Pathway* 210 , 2002, The Journal of Biological Chemistry.
[4] W. Birchmeier,et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[5] Y. Kaneda,et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats , 1999, Nature Medicine.
[6] D. Watson,et al. Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. , 2003, The American journal of pathology.
[7] T. Medsger,et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.
[8] C. Brinckerhoff,et al. Inhibition of rabbit collagenase (matrix metalloproteinase‐1; MMP‐1) transcription by retinoid receptors: Evidence for binding of RARs/RXRs to the −77 AP‐1 site through interactions with c‐Jun , 1996, Journal of cellular physiology.
[9] E. Imai,et al. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats , 1996, Hepatology.
[10] D. Watson,et al. Fli-1 Inhibits Collagen Type I Production in Dermal Fibroblasts via an Sp1-dependent Pathway* , 2001, The Journal of Biological Chemistry.
[11] J. Rutter,et al. Cell‐type specific regulation of human interstitial collagenase‐1 gene expression by interleukin‐1β (IL‐1β) in human fibroblasts and BC‐8701 breast cancer cells , 1997 .
[12] P. Boros,et al. Hepatocyte growth factor: a multifunctional cytokine , 1995, The Lancet.
[13] N. Kamatani,et al. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis. , 2002, The Journal of rheumatology.
[14] T. Nakamura,et al. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. , 1984, Biochemical and biophysical research communications.
[15] Michael Stoker,et al. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility , 1987, Nature.
[16] P. Flemming,et al. MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation--an immunohistochemical study. , 2002, Gynecologic oncology.
[17] J. Westermarck,et al. Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors , 1997, Oncogene.
[18] H. Ronday,et al. Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase. , 1997, The Biochemical journal.
[19] H. Shinkai,et al. Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis , 1997, Archives of Dermatological Research.
[20] V. Sementchenko,et al. Ets1 Is an Effector of the Transforming Growth Factor β (TGF-β) Signaling Pathway and an Antagonist of the Profibrotic Effects of TGF-β* , 2002, The Journal of Biological Chemistry.
[21] K. Matsumoto,et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis , 1997, Hepatology.
[22] E. CARwni LEROYwith,et al. Increased Collagen Synthesis by Scleroderma Skin Fibroblasts In Vitro A POSSIBLE DEFECT IN THE REGULATION OR ACTIVATION OF THE SCLERODERMA FIBROBLAST , 2022 .
[23] G. Michalopoulos,et al. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. , 1989, Cancer research.
[24] H. Ihn,et al. Transcriptional regulation of the human alpha2(I) collagen gene. Combined action of upstream stimulatory and inhibitory cis-acting elements. , 1996, The Journal of biological chemistry.
[25] T. Nakamura,et al. HGF triggers activation of the COX‐2 gene in rat gastric epithelial cells: action mediated through the ERK2 signaling pathway , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] Y. Taniyama,et al. Mitogenic and Antiapoptotic Actions of Hepatocyte Growth Factor Through ERK, STAT3, and Akt in Endothelial Cells , 2001, Hypertension.
[27] M. Harigai,et al. Increased levels of hepatocyte growth factor in sera of patients with systemic sclerosis. , 1999, The Journal of rheumatology.
[28] N. Bellamy,et al. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. , 2001, Arthritis and rheumatism.
[29] C. Brinckerhoff,et al. Erk 1/2 differentially regulates the expression from the 1G/2G single nucleotide polymorphism in the MMP-1 promoter in melanoma cells. , 2002, Biochimica et biophysica acta.
[30] K. Tashiro,et al. Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.
[31] I. Kola,et al. Regulation of gene expression by transcription factors Ets‐1 and Ets‐2 , 1994, Molecular reproduction and development.
[32] J. Rosenbloom,et al. Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts. , 1986, The Biochemical journal.
[33] I. Haznedaroglu,et al. Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis. , 2003, Arthritis and rheumatism.
[34] J. Westermarck,et al. Regulation of matrix metalloproteinase expression in tumor invasion , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] H. Ihn,et al. Oncostatin M Stimulates Transcription of the Human α2(I) Collagen Gene via the Sp1/Sp3-binding Site* , 1997, The Journal of Biological Chemistry.
[36] C. Hartl,et al. Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: insensitivity to TGF beta 1 stimulation. , 1992, Biochemical and biophysical research communications.
[37] Y. Wan,et al. Transmodulation of epidermal growth factor receptor mediates IL-1 beta-induced MMP-1 expression in cultured human keratinocytes. , 2001, International journal of molecular medicine.
[38] B. Wasylyk,et al. The c‐Ets oncoprotein activates the stromelysin promoter through the same elements as several non‐nuclear oncoproteins. , 1991, The EMBO journal.
[39] M. Roussel,et al. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma , 1994, Molecular and cellular biology.
[40] M. Jinnin,et al. Effects of hepatocyte growth factor on the expression of type I collagen and matrix metalloproteinase-1 in normal and scleroderma dermal fibroblasts. , 2005, The Journal of investigative dermatology.
[41] Kyosuke Yamamoto,et al. Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line. , 2002, Journal of hepatology.
[42] K. Matsumoto,et al. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. , 1995, Journal of biochemistry.
[43] R. Ilaria,et al. Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation , 2000, Oncogene.
[44] S. Jimenez,et al. Transcriptional activation of the alpha 1(I) procollagen gene in systemic sclerosis dermal fibroblasts. Role of intronic sequences. , 1996, Arthritis and rheumatism.
[45] D. Watson,et al. Ets transcription factors cooperate with Sp1 to activate the human Tenascin-C promoter , 1999, Oncogene.
[46] V. Sementchenko,et al. ETS2 function is required to maintain the transformed state of human prostate cancer cells , 1998, Oncogene.
[47] S. Hirono,et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. , 1988, The Journal of clinical investigation.
[48] K. Takeda,et al. Decreased collagenase expression in cultured systemic sclerosis fibroblasts. , 1994, The Journal of investigative dermatology.
[49] H. Ihn,et al. IL-4 Up-Regulates the Expression of Tissue Inhibitor of Metalloproteinase-2 in Dermal Fibroblasts Via the p38 Mitogen-Activated Protein Kinase-Dependent Pathway1 , 2002, The Journal of Immunology.